SEMAGLUTIDE FOR WEIGHT LOSS

CHARLOTTE NC | MATTHEWS NC

(704) 243-7106

Weight Loss Made Easier

Semaglutide is a new weight loss method that uses weekly injections to target and regulate appetite and food intake.

SEMAGLUTIDE FOR WEIGHT LOSS

CHARLOTTE NC | MATTHEWS NC

(704) 243-7106

Weight Loss Made Easier

Semaglutide is a new weight loss method that uses weekly injections to target and regulate appetite and food intake.

More About Semaglutide for Weight Loss

Semaglutide for weight loss is a non-stimulant (safe for patients with cardiovascular disease), non-addictive (not a controlled substance) weekly injection which was approved by the FDA for diabetes AND weight loss. It is a painless weekly injection that helps to reduce appetite and food cravings while increasing feeling of fullness. Semaglutide  helps lowers weight, waist size, blood pressure, blood sugar, and inflammation.

FAQs about Semaglutide

  • In  drug approval research trials, a majority of patients had at least 15% weight loss, with many losing more than 20%!

  • Semaglutide for weight loss works by mimicking a hormone called glucagon-like peptide-1 (GLP-1) that stimulates insulin secretion, delays gastric emptying, decreases glucagon levels and significantly reduces appetite.

  • Semaglutide was  approved by the FDA in 2021 for the treatment of obesity and has been safely used for diabetes since 2017.

Medication Disclosures: These injectable medications are obtained from compounding pharmacies licensed by the State Board of Pharmacy. Compounding pharmacies are currently able to produce these medications due to supply shortages as listed on the FDA Drug Shortage website. Compounded versions of medications are not evaluated by the FDA nor do they receive FDA approval, even if the branded parent compound is FDA approved. Our programs are NOT affiliated with Novo Nordisk or  Eli Lily and Company.

  • You are NOT a good candidate for semaglutide if you have any of the following: diabetic retinopathy, low blood sugar, decreased kidney function, pancreatitis, medullary thyroid cancer (or a family history of medullary thyroid carcinoma), or multiple endocrine neoplasia type 2.

More About Semaglutide for Weight Loss

Semaglutide for weight loss is an FDA approved non-stimulant (safe for patients with cardiovascular disease), non-addictive (not a controlled substance) weekly injection. It uses painless, weekly injection into belly fat with a tiny needle to reduces appetite and food cravings while increasing feeling of fullness. Semalglutide lowers weight, waist size, blood pressure, blood sugar, and inflammation.

FAQs about Semaglutide

  • Majority of patients had at least 15% weight loss, with many losing more than 20%!

  • Semaglutide for weight loss works by mimicking a hormone called glucagon-like peptide-1 (GLP-1) that targets areas of the brain that regulate appetite and food intake; it is a powerful appetite suppressant.

  • Semaglutide was  approved by the FDA in 2021 for the treatment of obesity and has been safely used for diabetes since 2017.
  • Medication Disclosures: These injectable medications are obtained from compounding pharmacies licensed by the State Board of Pharmacy. Compounding pharmacies are currently able to produce these medications due to supply shortages as listed on the FDA Drug Shortage website. Compounded versions of medications are not evaluated by the FDA nor do they receive FDA approval, even if the branded parent compound is FDA approved. Our programs are NOT affiliated with Novo Nordisk or  Eli Lily and Company.

  • You are NOT a good candidate for semaglutide if you have any of the following: diabetic retinopathy, low blood sugar, decreased kidney function, pancreatitis, medullary thyroid cancer (or a family history of medullary thyroid carcinoma), or multiple endocrine neoplasia type 2.